YOUSIF CAPITAL MANAGEMENT, LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1858789
BLOOMFIELD HILLS, MI
Position in NBIX
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$4,884,120
+$840,098 QoQ
Shares Held
28,979
-5.6% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#214
of 768 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 32%
Shared 0%
None 68%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026YOUSIF CAPITAL MANAGEMENT, LLC holds $35,190,450 across 18 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (13.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
12,446 | $6,743,616 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
28,979 | $4,884,120 | |
| 3 | ZTS |
Zoetis Inc.
|
53,813 | $3,867,002 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
146,732 | $3,611,074 | |
| 5 | ALKS |
Alkermes plc.
|
45,699 | $2,394,399 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
59,798 | $2,073,196 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
18,586 | $2,061,930 | |
| 8 | VTRS |
Viatris Inc
|
110,271 | $1,751,103 |
All Filings in NBIX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,884,120 | 28,979 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $4,044,022 | 30,697 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $4,545,084 | 32,046 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $4,565,297 | 32,521 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $4,364,836 | 34,727 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $3,942,337 | 35,645 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $5,056,369 | 37,043 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $4,447,722 | 38,602 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $5,989,333 | 43,505 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $6,408,039 | 46,462 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $6,167,422 | 46,808 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $5,307,525 | 47,178 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $4,689,821 | 49,733 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $5,160,094 | 50,979 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $6,067,432 | 50,799 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $5,278,424 | 49,698 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $5,291,409 | 54,282 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $4,877,531 | 52,027 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $4,290,012 | 50,370 | Shares | Sole | 2022-01-31 | |
| No filing history on record for this holder in this stock. | ||||||